Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and
marketer of diabetes testing supplies, announced today that Joseph
Capper, President and Chief Executive Officer, and Ronald Rubin, Chief
Financial Officer, of Home Diagnostics are scheduled to present at the
Deutsche Bank 34th Annual Health Care Conference at the
InterContinental Boston Hotel on Tuesday, May 19, 2009, at 3:15 p.m. ET.
A live Web cast of the presentation will be available on the Home
Diagnostics Web site at www.homediagnostics.com.
A replay of the Web cast will be available following the live
presentation and will remain on the site for 30 days.
About Home Diagnostics, Inc.
Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ:HDIX)
is a leading developer, manufacturer and marketer of diabetes management
solutions. Home Diagnostics, Inc. offers a portfolio of high-quality
blood glucose monitoring systems that spans the spectrum of features and
benefits to help every person with diabetes better monitor and manage
their disease. The Home Diagnostics, Inc. product line includes
TRUE2go™, TRUEresult™, TRUEbalance™, TRUEtrack®, Sidekick®, TRUEread™
and Prestige Smart System® blood glucose monitoring systems. The
products are available in more than 45,000 pharmacies throughout the
U.S. Home Diagnostics is the exclusive co-brand supplier of blood
glucose monitoring supplies for leading pharmacies including CVS, Rite
Aid and Walgreens as well as national distributors such as
AmerisourceBergen, Cardinal Health, McKesson and Invacare. Home
Diagnostics, Inc. was named one of Forbes magazine’s “200 Best Small
Companies” in 2008. For more information please visit www.homediagnostics.com.
TRUE2go, TRUEresult, TRUEtest, TRUEbalance, TRUEtrack, Sidekick,
TRUEread and Prestige Smart System are trademarks of Home Diagnostics,
Inc. All other trademarks are property of their respective owners.
[HDIX-F]
Home Diagnostics, Inc., Fort Lauderdale
Sabrina Rios,
Corporate Communications Manager, 954-332-2141
srios@hdidiabetes.com
or
The
Ruth Group
Nick Laudico (Investors), 646-536-7030
nlaudico@theruthgroup.com
